Revue medicale de Liege · 1999
[Cutaneous melanomas, a spectrum of emerging cancers in women of Wallonia. Outlook by the Mosan Study Group of Pigmented Neoplasms].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Piérard-Franchimont C, Arrese J E, Cornil F, Damseaux M, Darcis J M, Deleixhe-Mauhin F, Delvoye P, Fraiture A L, Gerardy-Goffin F, Giet-Lesuisse M, Goffin V, Henry F, Hermanne-Wolff P, Hermanns J F, Hermanns-Lê T, Heymans O, Letawe C, Nikkels A, Nikkels-Tassoudji N, d'Hauterive-Willemaers V P, Rakic L, Soyeur-Broux M, Sproten G, Uhoda I, Piérard G E
Аннотация
The Mosan Study Group of Pigmented Neoplasms was founded about 15 years ago. It has collected more than 20,000 cutaneous malignancies including melanomas and basal and squamous cell carcinomas. The incidence of these cancers is on the rise in Wallonia. In particular, malignant melanomas represent a spectrum of emerging cancers characterized by a proteiform biological outcome. They mostly affect young women. The major risk factor appears to be iterative and unwise ultraviolet exposures. The prevention of melanomas is basically founded on such a dogma and accordingly relies on sunscreens. However, controversies about their beneficial effects are rife and fueled by axiomas and contradictory sophisms. At the exception of surgery, the therapeutic options for the diverse types of melanomas do not yet fulfill the scope of evidence-based medicine.